{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-031593","form_type":"8-K/A","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2025-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.628808+00:00","generated_at":"2026-05-23T15:35:20.059277+00:00","sec_items":["1.01","3.02","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Unicycive Therapeutics corrects warrant expiration dates via 8-K/A amendment","bullets":["Filing corrects inadvertent clerical error in Expiration Date on Exhibits 4.2 and 4.3 (Amended Tranche B and C Warrants) from Original 8-K.","No other changes made to Original Filing; all terms of Exchange Agreement and Amended Certificate of Designation remain unchanged.","Original March 2024 event exchanged 43,649,000 Series A-2 Preferred shares for Series A-2 Prime Preferred and amended warrants with reduced share counts and revised exercise price of $1,000.","Corrected exhibits reflect accurate expiration dates; no impact on conversion prices or aggregate exercise amounts."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-031593","json":"https://secwatch.observer/filing/0001213900-25-031593.json","markdown":"https://secwatch.observer/filing/0001213900-25-031593.md","text":"https://secwatch.observer/filing/0001213900-25-031593.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/0001213900-25-031593-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025031593/ea0237290-8ka1_unicyc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T15:35:20.059277+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}